v3.25.1
Merger (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Feb. 28, 2025
Nov. 13, 2024
Nov. 05, 2024
Oct. 07, 2024
Dec. 11, 2023
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Sep. 30, 2024
Dec. 31, 2023
Dec. 31, 2022
Merger [Line Items]                      
Converted into shares   2.045                  
Additional shares           14,500,000   14,500,000      
Shares of common shares 150,000                    
Aggregate purchase price (in Dollars)           $ 5,000   $ 5,000      
Repay promissory note (in Dollars)           4,225   4,225      
Cash (in Dollars)           $ 1,261 $ 220 $ 2,850   $ 723  
Incentive shares           1,000,000   1,000,000      
Repayment of amount (in Dollars)       $ 1,000              
Forfeited number of shares         966,442            
Proceeds from financing (in Dollars)           $ 2,583        
Transaction costs (in Dollars)               $ 2,100      
Issuance costs (in Dollars)               900      
Liabilities net (in Dollars)               6,600      
Liabilities (in Dollars)               19,607 $ 18,577 16,191 $ 15,287
Accrued expenses (in Dollars)           $ 325   $ 325   379  
Merger amount (in Dollars) $ 0                    
Exercise price per share (in Dollars per share)               $ 3.83      
Exceeds per share (in Dollars per share)           $ 11.5   $ 11.5      
Legal fees (in Dollars)               $ 1,000      
Excise tax payable (in Dollars)           $ 4,401   4,401    
Income tax payable (in Dollars)           366   $ 366    
Warrant [Member]                      
Merger [Line Items]                      
Number of shares of warrant   2.04489              
Warrant, Exercise Price, Decrease (in Dollars per share)   $ 2.045                  
Exercise price per share (in Dollars per share)   $ 2.045                  
Promissory Note Agreement [Member]                      
Merger [Line Items]                      
Cash (in Dollars)           $ 2,000   $ 2,000      
First Shares Target [Member]                      
Merger [Line Items]                      
Earnout shares (in Dollars per share)               $ 13      
Trading days               20 days      
Consecutive trading days               30 days      
Exceeds per share (in Dollars per share)               $ 13      
Second Share Target [Member]                      
Merger [Line Items]                      
Earnout shares (in Dollars per share)               $ 15      
Trading days               20 days      
Consecutive trading days               30 days      
Exceeds per share (in Dollars per share)               $ 15      
Third Share Target [Member]                      
Merger [Line Items]                      
Earnout shares (in Dollars per share)               $ 18      
Trading days               20 days      
Consecutive trading days               30 days      
Exceeds per share (in Dollars per share)               $ 18      
PIPE Shares [Member]                      
Merger [Line Items]                      
Shares of common shares           3,367,401   3,367,401      
Aggregate purchase price (in Dollars)           $ 6,225   $ 6,225      
Abpro Bio International, Inc. [Member]                      
Merger [Line Items]                      
Shares of common shares           622,467   622,467      
ABI [Member]                      
Merger [Line Items]                      
Shares of common shares         983,333 1,244,934   1,244,934      
Sponsor [Member]                      
Merger [Line Items]                      
Shares of common shares         983,333            
Repayment of amount (in Dollars)           $ 2,000   $ 2,000      
ACAB [Member]                      
Merger [Line Items]                      
Shares of common shares         200,000            
Remaining shares issued           1,050,000          
Liabilities (in Dollars)           $ 5,800   5,800      
Accrued expenses (in Dollars)           1,000   1,000      
Tax payable (in Dollars)           4,400   4,400      
Income tax payable (in Dollars)           $ 400   $ 400      
PIPE Financing [Member]                      
Merger [Line Items]                      
Shares of common shares           1,082,852   1,082,852      
Proceeds from financing (in Dollars)           $ 5,700   $ 5,700      
Transaction costs (in Dollars)           2,100   2,100      
Issuance costs (in Dollars)           $ 900   $ 900      
Investment Advisor [Member]                      
Merger [Line Items]                      
Shares of common shares           32,852   32,852      
Legacy Abpro [Member]                      
Merger [Line Items]                      
Liabilities net (in Dollars)           $ 6,600   $ 6,600      
ABCD [Member]                      
Merger [Line Items]                      
Remaining shares issued               1,050,000      
Legal fees (in Dollars)               $ 1,000      
Preferred Stock [Member]                      
Merger [Line Items]                      
Converted into shares   2.045                  
Series A Common Stock [Member]                      
Merger [Line Items]                      
Converted shares of common stock           6,744,550   6,744,550      
Shares of common shares     11,043                
Series B Common Stock [Member]                      
Merger [Line Items]                      
Converted shares of common stock           1   1      
Common Stock [Member] | Celltrion, Inc. [Member]                      
Merger [Line Items]                      
Shares of common shares           500,000   500,000      
Common Stock [Member] | Sponsor [Member]                      
Merger [Line Items]                      
Shares of common shares           600,601   600,601      
Private Placement [Member]                      
Merger [Line Items]                      
Total consideration (in Dollars)           $ 11,225   $ 11,225